skip to content

News & Articles

Full Transcript: Dr Ranjit Manchanda, Clinical Senior Lecturer at Barts Cancer Institute, interviewed by Erin Brodwin of Business Insider

Linda Jiang

Dr. Ranjit Manchandra (left) and Erin Brodwin (right)

On this episode of Sequenced, Dr. Ranjit Manchanda, Clinical Senior Lecturer at Barts Cancer Institute in London, sits down with Business Insider’s Erin Brodwin to discuss population-based genetic testing for cancer prevention.

Dr. Manchanda’s recent research found that population testing for multiple breast cancer genes has the potential to be both cost-effective and life-saving. Curious to learn more? The research abstract can be found here.

We’ve posted complete transcript of the podcast below. You can subscribe to Sequenced on Apple Podcasts, SoundCloud, Stitcher, and Google Play.

Header image for JP Morgan 2022 Blog Post

Color takeaways from the J.P. Morgan Health Care Conference 2022

Meet Catherine Lacavera, Color’s new Chief Legal Officer

Color makes public health happen where public life happens

Image for blog post Color makes public health happen where public life happens

Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure